SARTORIUS AG (SRT.DE) Stock Fundamental Analysis
Europe - FRA:SRT - DE0007165607 - Common Stock
190.4 EUR
+1.6 (+0.85%)
Taking everything into account, SRT scores 3 out of 10 in our fundamental rating. SRT was compared to 20 industry peers in the Life Sciences Tools & Services industry. SRT may be in some trouble as it scores bad on both profitability and health. SRT is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year SRT was profitable.
SRT had a positive operating cash flow in the past year.
Each year in the past 5 years SRT has been profitable.
Each year in the past 5 years SRT had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 1.39%, SRT is doing worse than 70.00% of the companies in the same industry.
With a Return On Equity value of 5.01%, SRT is not doing good in the industry: 65.00% of the companies in the same industry are doing better.
SRT has a worse Return On Invested Capital (4.71%) than 70.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for SRT is in line with the industry average of 7.43%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.39% | ||
| ROE | 5.01% | ||
| ROIC | 4.71% |
ROA(3y)4.22%
ROA(5y)4.59%
ROE(3y)15.69%
ROE(5y)18.55%
ROIC(3y)8.34%
ROIC(5y)10.45%
1.3 Margins
SRT's Profit Margin of 3.80% is on the low side compared to the rest of the industry. SRT is outperformed by 70.00% of its industry peers.
SRT's Profit Margin has declined in the last couple of years.
The Operating Margin of SRT (14.06%) is comparable to the rest of the industry.
SRT's Operating Margin has declined in the last couple of years.
With a decent Gross Margin value of 46.48%, SRT is doing good in the industry, outperforming 75.00% of the companies in the same industry.
In the last couple of years the Gross Margin of SRT has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.06% | ||
| PM (TTM) | 3.8% | ||
| GM | 46.48% |
OM growth 3Y-21.14%
OM growth 5Y-7.77%
PM growth 3Y-35.47%
PM growth 5Y-21.95%
GM growth 3Y-5.43%
GM growth 5Y-2.63%
2. Health
2.1 Basic Checks
SRT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, SRT has more shares outstanding
Compared to 5 years ago, SRT has more shares outstanding
The debt/assets ratio for SRT has been reduced compared to a year ago.
2.2 Solvency
SRT has an Altman-Z score of 2.09. This is not the best score and indicates that SRT is in the grey zone with still only limited risk for bankruptcy at the moment.
SRT's Altman-Z score of 2.09 is on the low side compared to the rest of the industry. SRT is outperformed by 65.00% of its industry peers.
SRT has a debt to FCF ratio of 8.92. This is a slightly negative value and a sign of low solvency as SRT would need 8.92 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 8.92, SRT is in line with its industry, outperforming 45.00% of the companies in the same industry.
A Debt/Equity ratio of 1.28 is on the high side and indicates that SRT has dependencies on debt financing.
The Debt to Equity ratio of SRT (1.28) is worse than 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.28 | ||
| Debt/FCF | 8.92 | ||
| Altman-Z | 2.09 |
ROIC/WACC0.62
WACC7.6%
2.3 Liquidity
A Current Ratio of 0.95 indicates that SRT may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.95, SRT is doing worse than 80.00% of the companies in the same industry.
SRT has a Quick Ratio of 0.95. This is a bad value and indicates that SRT is not financially healthy enough and could expect problems in meeting its short term obligations.
SRT's Quick ratio of 0.49 is on the low side compared to the rest of the industry. SRT is outperformed by 85.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.95 | ||
| Quick Ratio | 0.49 |
3. Growth
3.1 Past
SRT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 59.34%, which is quite impressive.
SRT shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -11.87% yearly.
Looking at the last year, SRT shows a small growth in Revenue. The Revenue has grown by 5.82% in the last year.
SRT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.10% yearly.
EPS 1Y (TTM)59.34%
EPS 3Y-36.07%
EPS 5Y-11.87%
EPS Q2Q%24.23%
Revenue 1Y (TTM)5.82%
Revenue growth 3Y-0.67%
Revenue growth 5Y13.1%
Sales Q2Q%6.54%
3.2 Future
SRT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.16% yearly.
Based on estimates for the next years, SRT will show a quite strong growth in Revenue. The Revenue will grow by 8.92% on average per year.
EPS Next Y23.27%
EPS Next 2Y20.61%
EPS Next 3Y22.38%
EPS Next 5Y19.16%
Revenue Next Year5.14%
Revenue Next 2Y7.17%
Revenue Next 3Y8.54%
Revenue Next 5Y8.92%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 41.75, which means the current valuation is very expensive for SRT.
Compared to the rest of the industry, the Price/Earnings ratio of SRT indicates a slightly more expensive valuation: SRT is more expensive than 70.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.10, SRT is valued quite expensively.
The Price/Forward Earnings ratio is 31.94, which means the current valuation is very expensive for SRT.
Based on the Price/Forward Earnings ratio, SRT is valued a bit more expensive than 65.00% of the companies in the same industry.
SRT is valuated rather expensively when we compare the Price/Forward Earnings ratio to 22.52, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 41.75 | ||
| Fwd PE | 31.94 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as SRT.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SRT indicates a somewhat cheap valuation: SRT is cheaper than 70.00% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 29.79 | ||
| EV/EBITDA | 19.43 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as SRT's earnings are expected to grow with 22.38% in the coming years.
PEG (NY)1.79
PEG (5Y)N/A
EPS Next 2Y20.61%
EPS Next 3Y22.38%
5. Dividend
5.1 Amount
SRT has a yearly dividend return of 0.39%, which is pretty low.
SRT's Dividend Yield is comparable with the industry average which is at 0.69.
With a Dividend Yield of 0.39, SRT pays less dividend than the S&P500 average, which is at 2.35.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.39% |
5.2 History
The dividend of SRT has a limited annual growth rate of 3.71%.
Dividend Growth(5Y)3.71%
Div Incr Years3
Div Non Decr Years3
5.3 Sustainability
SRT pays out 37.92% of its income as dividend. This is a sustainable payout ratio.
SRT's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP37.92%
EPS Next 2Y20.61%
EPS Next 3Y22.38%
FRA:SRT (10/31/2025, 7:00:00 PM)
190.4
+1.6 (+0.85%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners4.37%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap14.26B
Revenue(TTM)3.52B
Net Income(TTM)133.70M
Analysts80
Price Target269.28 (41.43%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.39% |
Yearly Dividend0.74
Dividend Growth(5Y)3.71%
DP37.92%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.8%
Min EPS beat(2)-10.52%
Max EPS beat(2)4.91%
EPS beat(4)1
Avg EPS beat(4)-3.45%
Min EPS beat(4)-10.52%
Max EPS beat(4)4.91%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.18%
Min Revenue beat(2)-0.73%
Max Revenue beat(2)1.1%
Revenue beat(4)3
Avg Revenue beat(4)1.98%
Min Revenue beat(4)-0.73%
Max Revenue beat(4)4.87%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-11.32%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-13.11%
EPS NY rev (1m)0%
EPS NY rev (3m)0.3%
Revenue NQ rev (1m)2.88%
Revenue NQ rev (3m)2.88%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)-1.16%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 41.75 | ||
| Fwd PE | 31.94 | ||
| P/S | 4.05 | ||
| P/FCF | 29.79 | ||
| P/OCF | 16.31 | ||
| P/B | 5.34 | ||
| P/tB | N/A | ||
| EV/EBITDA | 19.43 |
EPS(TTM)4.56
EY2.39%
EPS(NY)5.96
Fwd EY3.13%
FCF(TTM)6.39
FCFY3.36%
OCF(TTM)11.68
OCFY6.13%
SpS46.97
BVpS35.63
TBVpS-35.24
PEG (NY)1.79
PEG (5Y)N/A
Graham Number60.46
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.39% | ||
| ROE | 5.01% | ||
| ROCE | 6.33% | ||
| ROIC | 4.71% | ||
| ROICexc | 4.98% | ||
| ROICexgc | 17.77% | ||
| OM | 14.06% | ||
| PM (TTM) | 3.8% | ||
| GM | 46.48% | ||
| FCFM | 13.61% |
ROA(3y)4.22%
ROA(5y)4.59%
ROE(3y)15.69%
ROE(5y)18.55%
ROIC(3y)8.34%
ROIC(5y)10.45%
ROICexc(3y)8.77%
ROICexc(5y)11.17%
ROICexgc(3y)24.37%
ROICexgc(5y)31.52%
ROCE(3y)11.22%
ROCE(5y)14.06%
ROICexgc growth 3Y-35.26%
ROICexgc growth 5Y-11.95%
ROICexc growth 3Y-38.49%
ROICexc growth 5Y-19.53%
OM growth 3Y-21.14%
OM growth 5Y-7.77%
PM growth 3Y-35.47%
PM growth 5Y-21.95%
GM growth 3Y-5.43%
GM growth 5Y-2.63%
F-Score7
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.28 | ||
| Debt/FCF | 8.92 | ||
| Debt/EBITDA | 3.69 | ||
| Cap/Depr | 92.32% | ||
| Cap/Sales | 11.25% | ||
| Interest Coverage | 2.65 | ||
| Cash Conversion | 94.72% | ||
| Profit Quality | 357.97% | ||
| Current Ratio | 0.95 | ||
| Quick Ratio | 0.49 | ||
| Altman-Z | 2.09 |
F-Score7
WACC7.6%
ROIC/WACC0.62
Cap/Depr(3y)148.03%
Cap/Depr(5y)150.65%
Cap/Sales(3y)13.71%
Cap/Sales(5y)12.64%
Profit Quality(3y)282.77%
Profit Quality(5y)224.27%
High Growth Momentum
Growth
EPS 1Y (TTM)59.34%
EPS 3Y-36.07%
EPS 5Y-11.87%
EPS Q2Q%24.23%
EPS Next Y23.27%
EPS Next 2Y20.61%
EPS Next 3Y22.38%
EPS Next 5Y19.16%
Revenue 1Y (TTM)5.82%
Revenue growth 3Y-0.67%
Revenue growth 5Y13.1%
Sales Q2Q%6.54%
Revenue Next Year5.14%
Revenue Next 2Y7.17%
Revenue Next 3Y8.54%
Revenue Next 5Y8.92%
EBIT growth 1Y18.65%
EBIT growth 3Y-21.66%
EBIT growth 5Y4.31%
EBIT Next Year99.69%
EBIT Next 3Y38.21%
EBIT Next 5Y26.49%
FCF growth 1Y123.33%
FCF growth 3Y7.25%
FCF growth 5Y29.73%
OCF growth 1Y6.61%
OCF growth 3Y4.07%
OCF growth 5Y20.79%
SARTORIUS AG / SRT.DE FAQ
What is the ChartMill fundamental rating of SARTORIUS AG (SRT.DE) stock?
ChartMill assigns a fundamental rating of 3 / 10 to SRT.DE.
Can you provide the valuation status for SARTORIUS AG?
ChartMill assigns a valuation rating of 2 / 10 to SARTORIUS AG (SRT.DE). This can be considered as Overvalued.
Can you provide the profitability details for SARTORIUS AG?
SARTORIUS AG (SRT.DE) has a profitability rating of 3 / 10.
What is the expected EPS growth for SARTORIUS AG (SRT.DE) stock?
The Earnings per Share (EPS) of SARTORIUS AG (SRT.DE) is expected to grow by 23.27% in the next year.
Can you provide the dividend sustainability for SRT stock?
The dividend rating of SARTORIUS AG (SRT.DE) is 4 / 10 and the dividend payout ratio is 37.92%.